A detailed history of Foresight Capital Management Advisors, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Foresight Capital Management Advisors, Inc. holds 52,949 shares of OGN stock, worth $895,897. This represents 0.61% of its overall portfolio holdings.

Number of Shares
52,949
Holding current value
$895,897
% of portfolio
0.61%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$18.65 - $23.03 $987,498 - $1.22 Million
52,949 New
52,949 $1.01 Million
Q2 2022

Jul 11, 2022

SELL
$31.66 - $38.9 $158 - $194
-5 Closed
0 $0
Q4 2021

May 04, 2022

BUY
$28.67 - $37.13 $143 - $185
5 New
5 $0

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.3B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Foresight Capital Management Advisors, Inc. Portfolio

Follow Foresight Capital Management Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresight Capital Management Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Foresight Capital Management Advisors, Inc. with notifications on news.